{"id":"blood-components-transfusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Transfusion reaction (acute hemolytic)"},{"rate":null,"effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":null,"effect":"Febrile non-hemolytic transfusion reaction"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Infection (viral, bacterial, parasitic)"},{"rate":null,"effect":"Iron overload (with chronic transfusion)"}]},"_chembl":{"chemblId":"CHEMBL2108414","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Transfusion of blood components (red blood cells, platelets, plasma, cryoprecipitate) directly replenishes circulating blood elements lost through hemorrhage, hemolysis, or bone marrow failure. This restores oxygen delivery to tissues, corrects coagulopathy, and supports immune function. The mechanism is physiologic replacement rather than pharmacologic.","oneSentence":"Blood components transfusion replaces deficient or lost blood cells and plasma factors to restore oxygen-carrying capacity, hemostasis, and immune function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:04:30.253Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hemorrhage requiring volume and oxygen-carrying capacity restoration"},{"name":"Severe anemia"},{"name":"Thrombocytopenia with bleeding risk"},{"name":"Coagulopathy or clotting factor deficiency"},{"name":"Bone marrow failure or aplasia"}]},"trialDetails":[{"nctId":"NCT00023023","phase":"","title":"Study of Transfusion-Transmitted Infections","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2002-01-17","conditions":"Viral Disease, Blood Donation, Transfusion-Transmitted Infections","enrollment":1771},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT07437755","phase":"NA","title":"Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures","status":"RECRUITING","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2025-06-01","conditions":"Liver Cirrhosis With Acute Decompensation","enrollment":116},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT07420296","phase":"PHASE4","title":"Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder","status":"RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2026-01-01","conditions":"Neuromyelitis Optica Spectrum Disorders (NMOSD)","enrollment":198},{"nctId":"NCT02201576","phase":"PHASE2","title":"Bortezomib in Rejection of Kidney Transplants","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-02-11","conditions":"Chronic Antibody-mediated Transplant Rejection","enrollment":60},{"nctId":"NCT04684719","phase":"PHASE3","title":"Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial","status":"COMPLETED","sponsor":"Jason Sperry","startDate":"2022-04-19","conditions":"Hemorrhagic Shock, Traumatic Injury","enrollment":1020},{"nctId":"NCT04431999","phase":"PHASE3","title":"Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2021-12-04","conditions":"Trauma, Acute Hemorrhage, Coagulopathy","enrollment":200},{"nctId":"NCT05399693","phase":"","title":"Platelet Transfusion Refractoriness","status":"COMPLETED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2022-02-02","conditions":"Platelet Transfusion Refractoriness","enrollment":50},{"nctId":"NCT06562803","phase":"NA","title":"Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis","status":"RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-09-27","conditions":"Acute-On-Chronic Liver Failure, Sepsis","enrollment":60},{"nctId":"NCT04137692","phase":"NA","title":"Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2027-09","conditions":"Glucose Transporter Type 1 Deficiency Syndrome, GLUT1DS1","enrollment":12},{"nctId":"NCT07087860","phase":"PHASE2","title":"Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-01","conditions":"Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma","enrollment":70},{"nctId":"NCT06298643","phase":"","title":"Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2023-12-22","conditions":"Lower-risk Myelodysplastic Syndromes","enrollment":177},{"nctId":"NCT02570542","phase":"PHASE2","title":"Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-10","conditions":"Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":59},{"nctId":"NCT06483139","phase":"","title":"Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-06-01","conditions":"Multiple Myeloma, Light Chain Nephropathy, Acute Kidney Injury","enrollment":450},{"nctId":"NCT05405426","phase":"NA","title":"Trial of Indication-Based Transfusion of Red Blood Cells in ECMO","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2023-04-14","conditions":"Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple","enrollment":228},{"nctId":"NCT04057872","phase":"PHASE1","title":"Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis","status":"COMPLETED","sponsor":"Alberta Health Services, Calgary","startDate":"2020-10-21","conditions":"Septic Shock","enrollment":17},{"nctId":"NCT05509439","phase":"NA","title":"Home Transfusion for HEME","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-10-18","conditions":"Hematologic Malignancy","enrollment":10},{"nctId":"NCT04074187","phase":"PHASE2, PHASE3","title":"A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-10-21","conditions":"Thrombotic Thrombocytopenic Purpura","enrollment":21},{"nctId":"NCT03459287","phase":"PHASE3","title":"Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Cerus Corporation","startDate":"2018-12-05","conditions":"Anemia","enrollment":581},{"nctId":"NCT06043050","phase":"","title":"PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2022-09-26","conditions":"Neonatal Thrombocytopenia, Intraventricular Hemorrhage, Platelet Transfusion","enrollment":1042},{"nctId":"NCT06272084","phase":"","title":"Analysis of TPE Treatments With multiFiltratePRO","status":"RECRUITING","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2024-05-22","conditions":"Autoimmune Diseases","enrollment":60},{"nctId":"NCT05638581","phase":"PHASE3","title":"Trauma Resuscitation With Low-Titer Group O Whole Blood or Products","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2023-07-27","conditions":"Wounds and Injuries, Shock, Hemorrhagic","enrollment":1100},{"nctId":"NCT07129031","phase":"PHASE3","title":"Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock","status":"NOT_YET_RECRUITING","sponsor":"Xijing Hospital","startDate":"2025-09-01","conditions":"Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB)","enrollment":180},{"nctId":"NCT05093075","phase":"PHASE2","title":"Therapeutic Plasma Exchange in Septic Shock: A Pilot Study","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-06-01","conditions":"Septic Shock","enrollment":80},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT05081063","phase":"PHASE3","title":"Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2022-03-05","conditions":"Hemorrhagic Shock, Acute Blood Loss Anemia, Traumatic Brain Injury","enrollment":199},{"nctId":"NCT04935177","phase":"PHASE3","title":"Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx","status":"COMPLETED","sponsor":"Hansa Biopharma AB","startDate":"2021-10-14","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":64},{"nctId":"NCT03542279","phase":"NA","title":"CPI Combination Therapy for Autoimmune Encephalitis","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2020-11-25","conditions":"Autoimmune Encephalitis","enrollment":70},{"nctId":"NCT06607016","phase":"PHASE2","title":"A Clinical Trial With KJ103 in Anti-GBM Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Bao Pharmaceuticals Co., Ltd.","startDate":"2024-10-21","conditions":"Anti-Glomerular Basement Membrane Disease","enrollment":12},{"nctId":"NCT05814094","phase":"NA","title":"Red Blood Cell Transfusion in ECMO - A Feasibility Trial","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2023-09-20","conditions":"Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication, Disability Physical","enrollment":120},{"nctId":"NCT05796557","phase":"PHASE4","title":"ECMO Hemostatic Transfusions in Children","status":"COMPLETED","sponsor":"Yale University","startDate":"2023-12-12","conditions":"Extracorporeal Membrane Oxygenation Complication, Hemorrhage, Thromboembolism","enrollment":50},{"nctId":"NCT06952361","phase":"","title":"Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients","status":"COMPLETED","sponsor":"Ardak Arynov","startDate":"2019-03-08","conditions":"Anemia, Blood Transfusion, Cancer","enrollment":107},{"nctId":"NCT01350232","phase":"NA","title":"Treatment of Sickle Cell Anemia With Stem Cell Transplant","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2009-09","conditions":"Sickle Cell Anemia, Sickle Cell-hemoglobin C Disease, Sickle Cell-β0-thalassemia","enrollment":2},{"nctId":"NCT04685655","phase":"NA","title":"RescuE pLAsma eXchange in Severe COVID-19","status":"TERMINATED","sponsor":"Heidelberg University","startDate":"2020-01-07","conditions":"Therapeutic Plasma Exchange, Covid19","enrollment":67},{"nctId":"NCT03994783","phase":"PHASE3","title":"Transplant Antibody-Mediated Rejection: Guiding Effective Treatments","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2019-07-17","conditions":"Kidney Transplant Rejection, Antibody-mediated Rejection","enrollment":3},{"nctId":"NCT06560164","phase":"NA","title":"Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-11-26","conditions":"Transfusion, Red Blood Cell, Extracorporeal Membrane Oxygenation","enrollment":526},{"nctId":"NCT04920045","phase":"NA","title":"A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2022-02-01","conditions":"Anemia, Red Blood Cell Transfusion, Fatigability","enrollment":23},{"nctId":"NCT02926274","phase":"","title":"Transfusion Using Stored Whole Blood","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-10-18","conditions":"Trauma, Hemorrhage, Coagulopathy","enrollment":330},{"nctId":"NCT00120263","phase":"NA","title":"Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma","status":"COMPLETED","sponsor":"London Health Sciences Centre","startDate":"1998-09","conditions":"Multiple Myeloma, Acute Renal Failure","enrollment":92},{"nctId":"NCT06382675","phase":"NA","title":"Clinical Performance of the New Plasma Filter PX2 in TPE Treatments","status":"RECRUITING","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2024-07-18","conditions":"Autoimmune Diseases","enrollment":46},{"nctId":"NCT05726825","phase":"NA","title":"Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock","status":"RECRUITING","sponsor":"Hannover Medical School","startDate":"2025-02-19","conditions":"Septic Shock","enrollment":274},{"nctId":"NCT06328647","phase":"NA","title":"Quantra Point-of-Care Hemostasis Monitoring","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-10-03","conditions":"Bleeding, Hemostatic Disorder","enrollment":666},{"nctId":"NCT06187220","phase":"","title":"Plasma Exchange for Amanita Toxin-induced Acute Liver Failure","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2024-01-01","conditions":"Acute Liver Failure","enrollment":111},{"nctId":"NCT06495294","phase":"NA","title":"SWiFT Canada (Study of Whole Blood in Frontline Trauma)","status":"RECRUITING","sponsor":"Unity Health Toronto","startDate":"2024-12-16","conditions":"Trauma","enrollment":60},{"nctId":"NCT06855667","phase":"NA","title":"Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-03-03","conditions":"Autoimmune Hepatitis","enrollment":50},{"nctId":"NCT05634109","phase":"PHASE3","title":"Whole Blood in Trauma Patients With Hemorrhagic Shock","status":"RECRUITING","sponsor":"Fundacion Clinica Valle del Lili","startDate":"2023-01-14","conditions":"Trauma, Trauma Injury, Trauma, Multiple","enrollment":220},{"nctId":"NCT01196715","phase":"PHASE3","title":"Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2010-11-01","conditions":"Myelodysplastic Syndrome","enrollment":360},{"nctId":"NCT04667468","phase":"PHASE2","title":"Cold Stored Platelet in Hemorrhagic Shock","status":"COMPLETED","sponsor":"Jason Sperry","startDate":"2022-06-21","conditions":"Trauma, Hemorrhage","enrollment":200},{"nctId":"NCT06698991","phase":"NA","title":"Daily Versus Alternate Day Plasma Exchange in Wilson Disease With Acute Liver Failure in Children","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-11-10","conditions":"Acute Liver Failure, Wilson Disease","enrollment":20},{"nctId":"NCT04776850","phase":"EARLY_PHASE1","title":"Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-12-29","conditions":"Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia","enrollment":""},{"nctId":"NCT06652516","phase":"NA","title":"Comparison Between Centrifugation Based and Membrane Based Plasma Exchange","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-05","conditions":"Therapeutic Plasma Exchange","enrollment":20},{"nctId":"NCT01639690","phase":"PHASE1","title":"ß-Thalassemia Major with Autologous CD34+ Hematopoietic Progenitor Cells Transduced with TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene","status":"ACTIVE_NOT_RECRUITING","sponsor":"San Rocco Therapeutics","startDate":"2012-07","conditions":"Confirmed Diagnosis of ß-thalassemia Major","enrollment":10},{"nctId":"NCT04973488","phase":"NA","title":"Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients","status":"COMPLETED","sponsor":"Novacescu Alexandru","startDate":"2020-07-25","conditions":"COVID-19 Pneumonia, COVID-19 Respiratory Infection, Acute Respiratory Failure","enrollment":38},{"nctId":"NCT05293106","phase":"PHASE4","title":"Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-07-05","conditions":"Cardiopulmonary Bypass Surgery","enrollment":9},{"nctId":"NCT04302805","phase":"PHASE3","title":"rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)","status":"COMPLETED","sponsor":"Institute for Clinical and Experimental Medicine","startDate":"2020-07-27","conditions":"Kidney Transplantation","enrollment":17},{"nctId":"NCT06535360","phase":"PHASE4","title":"Efficacy of Pathogen Inactivation Strategies for Platelet Transfusion","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-09-01","conditions":"Cardiopulmonary Bypass Surgery","enrollment":150},{"nctId":"NCT06534450","phase":"PHASE3","title":"The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dobri Kiprov","startDate":"2022-09-12","conditions":"Aging","enrollment":40},{"nctId":"NCT00953771","phase":"PHASE2","title":"Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2008-10","conditions":"Thrombotic Thrombocytopenic Purpura","enrollment":9},{"nctId":"NCT06244264","phase":"NA","title":"The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2024-03-15","conditions":"Spinal Metastases, Blood Transfusion Complication, Lung Cancer","enrollment":118},{"nctId":"NCT06355726","phase":"NA","title":"Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-04-09","conditions":"Alcoholic Hepatitis","enrollment":60},{"nctId":"NCT02889133","phase":"NA","title":"Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-01","conditions":"Iron Deficiency","enrollment":79},{"nctId":"NCT04623255","phase":"PHASE2","title":"Study of Plasma Exchange in Severe COVID-19","status":"COMPLETED","sponsor":"University College, London","startDate":"2020-10-16","conditions":"COVID19","enrollment":23},{"nctId":"NCT02981407","phase":"PHASE3","title":"Myocardial Ischemia and Transfusion","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2017-04-25","conditions":"Myocardial Infarction, Anemia","enrollment":3506},{"nctId":"NCT04871035","phase":"","title":"Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2021-04-28","conditions":"GBS","enrollment":20},{"nctId":"NCT05699005","phase":"PHASE1","title":"Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO","status":"UNKNOWN","sponsor":"University Hospital, Lille","startDate":"2023-09-18","conditions":"Cardiogenic Shock, Extracorporeal Membrane Oxygenation, Transfusion Related Complication","enrollment":238},{"nctId":"NCT06184828","phase":"PHASE3","title":"Pilot Study of Whole Blood Transfusion for Trauma Brain Injury (TBI)","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2024-08-01","conditions":"Traumatic Brain Injury","enrollment":100},{"nctId":"NCT04020224","phase":"NA","title":"INTERCEPT Safety Evaluation on Whole Blood","status":"WITHDRAWN","sponsor":"Swiss Transfusion SRC","startDate":"2024-01","conditions":"Safety Issues","enrollment":""},{"nctId":"NCT04454723","phase":"NA","title":"Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2020-08-14","conditions":"Hematologic Malignancy","enrollment":20},{"nctId":"NCT03897205","phase":"PHASE2","title":"An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients","status":"COMPLETED","sponsor":"Hansa Biopharma AB","startDate":"2019-04-30","conditions":"Kidney Transplant Rejection","enrollment":30},{"nctId":"NCT06276907","phase":"NA","title":"An Open-label Randomized Controlled Trial Comparing the Role of Therapeutic Plasma-exchange in Ameliorating Secondary Organ Dysfunctions in Patients With ACLF and Develop Biomarkers of Treatment Response","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-03-01","conditions":"Acute on Chronic Liver Failure","enrollment":190},{"nctId":"NCT06136715","phase":"","title":"Massive Transfusion in Trauma Patient Registry","status":"UNKNOWN","sponsor":"Methodist Health System","startDate":"2023-07-13","conditions":"Trauma","enrollment":500},{"nctId":"NCT02622854","phase":"NA","title":"Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-06","conditions":"Acute Pancreatitis","enrollment":22},{"nctId":"NCT00202371","phase":"PHASE4","title":"Transfusion Effects in Myelodysplastic Patients: Limiting Exposure","status":"WITHDRAWN","sponsor":"Sanquin Research & Blood Bank Divisions","startDate":"2002-07","conditions":"Myelodysplastic Syndromes","enrollment":""},{"nctId":"NCT06084351","phase":"PHASE3","title":"Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection","status":"WITHDRAWN","sponsor":"Larkin Community Hospital","startDate":"2020-05-12","conditions":"Covid19","enrollment":""},{"nctId":"NCT03772717","phase":"NA","title":"Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"TERMINATED","sponsor":"Emory University","startDate":"2022-02-22","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":2},{"nctId":"NCT05038722","phase":"","title":"Function of Platelets Used for Transfusions","status":"ENROLLING_BY_INVITATION","sponsor":"Sofia Ramström","startDate":"2018-11-22","conditions":"Thrombocytopenia, Hematologic Malignancy","enrollment":240},{"nctId":"NCT05930639","phase":"NA","title":"The Effect of the Care Bundle to be Applied to Obesity Surgery Patients on Surgical Site Infection and Patient Comfort","status":"UNKNOWN","sponsor":"Malatya Turgut Ozal University","startDate":"2023-06-12","conditions":"Bariatric Surgery Candidate","enrollment":70},{"nctId":"NCT04927988","phase":"NA","title":"Blood Components Changes by Using of Ringer's Lactated as Detergent In Autologous Blood Cell Transfusion","status":"WITHDRAWN","sponsor":"Maternal and Child Health Hospital of Foshan","startDate":"2021-10","conditions":"Placenta Accreta Spectrum","enrollment":""},{"nctId":"NCT03888417","phase":"","title":"TPE in Rennes Hospital","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2018-08-15","conditions":"Therapeutic Plasma Exchange","enrollment":190},{"nctId":"NCT03983694","phase":"","title":"Cerebral Haemodynamic Changes by Red Blood Cell Transfusion in Neonates","status":"COMPLETED","sponsor":"Gorm Greisen","startDate":"2019-06-20","conditions":"Cerebral Haemodynamics, Erythrocyte Transfusion","enrollment":18},{"nctId":"NCT00512577","phase":"PHASE3","title":"Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)","status":"TERMINATED","sponsor":"NHS Blood and Transplant","startDate":"2007-07","conditions":"Sickle Cell Disease","enrollment":70},{"nctId":"NCT03045068","phase":"PHASE4","title":"Platelet Transfusion During Neonatal Open Heart Surgery","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-04-11","conditions":"Cardiac Disease, Cardiac Surgery, Cardiopulmonary Bypass","enrollment":46},{"nctId":"NCT04441996","phase":"PHASE4","title":"Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity","status":"COMPLETED","sponsor":"Emory University","startDate":"2020-07-17","conditions":"COVID-19","enrollment":20},{"nctId":"NCT04915287","phase":"PHASE4","title":"Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2021-06-06","conditions":"Thrombocytopenia; Drugs, Chronic Liver Disease","enrollment":476},{"nctId":"NCT04539275","phase":"PHASE3","title":"VA CoronavirUs Research and Efficacy Studies-1","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2020-11-16","conditions":"COVID-19","enrollment":75},{"nctId":"NCT04303416","phase":"PHASE2, PHASE3","title":"Plasma Exchange With Albumin in AMN Patients","status":"COMPLETED","sponsor":"Pujol, Aurora, M.D.","startDate":"2020-03-09","conditions":"Adrenomyeloneuropathy, Adrenoleukodystrophy","enrollment":5},{"nctId":"NCT01435746","phase":"NA","title":"Transfusion Requirements After Orthotopic Liver Transplantation","status":"WITHDRAWN","sponsor":"University Medical Center Goettingen","startDate":"2011-11","conditions":"Anemia","enrollment":""},{"nctId":"NCT04988620","phase":"NA","title":"Cold Stored Whole Blood in Cardiothoracic Surgery","status":"UNKNOWN","sponsor":"Haukeland University Hospital","startDate":"2021-06-04","conditions":"Bleeding","enrollment":80},{"nctId":"NCT02074436","phase":"PHASE2","title":"PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)","status":"TERMINATED","sponsor":"Emory University","startDate":"2014-05-23","conditions":"Hematological Malignancies, Thrombocytopenia","enrollment":29},{"nctId":"NCT04460222","phase":"NA","title":"Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-11-16","conditions":"Cirrhosis, Liver","enrollment":60},{"nctId":"NCT05054894","phase":"EARLY_PHASE1","title":"Plasmapheresis for Treatment of Age-Related Frailty","status":"UNKNOWN","sponsor":"Neurological Associates of West Los Angeles","startDate":"2021-03-19","conditions":"Age-Related Frailty","enrollment":100},{"nctId":"NCT04457349","phase":"NA","title":"Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2020-07-25","conditions":"COVID 19","enrollment":10},{"nctId":"NCT02648113","phase":"NA","title":"Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-03-23","conditions":"Myocardial Infarction, Anemia, Blood Transfusion","enrollment":668},{"nctId":"NCT04374539","phase":"PHASE2","title":"Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial","status":"TERMINATED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2020-04-29","conditions":"Coronavirus","enrollment":36},{"nctId":"NCT04383756","phase":"EARLY_PHASE1","title":"Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2020-12","conditions":"Transfusion Related Complication, Liver Transplant","enrollment":""},{"nctId":"NCT04431375","phase":"NA","title":"Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-06-22","conditions":"Acute-On-Chronic Liver Failure, Hepatitis B","enrollment":70},{"nctId":"NCT05182515","phase":"PHASE3","title":"Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies","status":"UNKNOWN","sponsor":"Centre Hospitalier St Anne","startDate":"2021-12-22","conditions":"COVID-19","enrollment":50},{"nctId":"NCT01500681","phase":"","title":"Maintenance Plasma Exchange for Neuromyelitis Optica","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-06","conditions":"Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis","enrollment":9}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":39,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Blood components transfusion","genericName":"Blood components transfusion","companyName":"Oregon Health and Science University","companyId":"oregon-health-and-science-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"Blood components transfusion replaces deficient or lost blood cells and plasma factors to restore oxygen-carrying capacity, hemostasis, and immune function. Used for Acute hemorrhage requiring volume and oxygen-carrying capacity restoration, Severe anemia, Thrombocytopenia with bleeding risk.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}